Topics

ExCellThera to launch trials to assess cord blood cell-boosting drug

04:44 EST 7 Nov 2019 | SmartBrief

Canadian researchers have found a small-molecule drug, ECT-001, or UM171, has the potential to increase cord blood stem cell  -More

Original Article: ExCellThera to launch trials to assess cord blood cell-boosting drug

NEXT ARTICLE

More From BioPortfolio on "ExCellThera to launch trials to assess cord blood cell-boosting drug"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...